Mobile

A study to provide access to continued treatment for subjects with prostate cancer who are currently participating in an enzalutamide clinical study

Mise à jour : Il y a 4 ans
Référence : EUCTR2016-001694-32

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The objective of the study is to provide access to continued treatment for subjects who are currently participating in an enzalutamide clinical study for their prostate cancer and who are continuing to derive clinical benefit based on the assessment of the investigator.

Critère d'inclusion

  • Metastatic Castration Resistant Prostate Cancer

Liens